Applications of bacillus Calmette–Guerin and recombinant bacillus Calmette–Guerin in vaccine development and tumor immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Applications of bacillus Calmette–Guerin and recombinant bacillus Calmette–Guerin in vaccine development and tumor immunotherapy

Published:2015-08-12 Issue:9 Volume:14 Page:1255-1275
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Zheng Yuan-qiang¹,Naguib Youssef W²,Dong Yixuan²,Shi Yan-chun¹,Bou Shorgan³,Cui Zhengrong¹²

Affiliation:

1. 1Inner Mongolia Key Laboratory of Molecular Biology, Inner Mongolia Medical University, Hohhot 010059, China

2. 2Pharmaceutics Division, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA

3. 3National Research Center for Animal Transgenic Biotechnology, Inner Mongolia University, Hohhot, China

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1586/14760584.2015.1068124

Reference207 articles.

1. New Agents for Bacillus Calmette-Guérin–Refractory Bladder Cancer

2. Systemic and Mucosal Immune Responses after Intranasal Administration of Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Expressing Glutathione S -Transferase from Schistosoma haematobium

3. Oral Recombinant Mycobacterium bovis Bacillus Calmette–Guérin Expressing HIV-1 Antigens as a Freeze-Dried Vaccine Induces Long-Term, HIV-Specific Mucosal and Systemic Immunity

4. Combined intrarectal/intradermal inoculation of recombinant Mycobacterium bovis bacillus Calmette–Guérin (BCG) induces enhanced immune responses against the inserted HIV-1 V3 antigen

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Signature GXYLT2 Is Correlated with Immune Infiltration in Bladder Cancer;Disease Markers;2022-10-10

2. CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer;Cancers;2022-10-05

3. Actualités du BCG;La Presse Médicale Formation;2022-09

4. Genetically modified cancer vaccines: Current status and future prospects;Medicinal Research Reviews;2022-03-02

5. Novel molecules as the emerging trends in cancer treatment: an update;Medical Oncology;2022-01-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3